Health in the Union Budget 2026-27: Lofty Promises, Hollow Priorities
The Union Budget 2026-27 has once again showcased the government’s ability to craft eloquent rhetoric around healthcare reform while systematically underfunding vital public health programmes. The modest overall increase in healthcare allocations—₹1,10,939 crore up from ₹1,03,851 crore last year—has translated to less than 3.5% growth in real terms after accounting for inflation. With health expenditure as a share of GDP falling to a mere 0.28% from 0.37% in 2020-21, India’s healthcare priorities seem increasingly at odds with its public health challenges.
Institutional Landscape: Allocation Trends
The Ministry of Health and Family Welfare and AYUSH received ₹1,10,939 crore in total allocations for 2026-27, reflecting nominal growth. However, health’s share in the Union Budget declined from 2.26% to 2.07% since 2020-21. The National Health Mission (NHM)—the backbone of India’s health infrastructure—has suffered an 8% real-term decline in funding compared to 2021-22. This is alarming, given NHM consistently exceeds budget estimates in actual expenditure, highlighting unmet demand for services ranging from maternal healthcare to non-communicable disease management. By contrast, PMJAY’s allocation increased by 36% compared to 2024-25, despite implementation gaps, uneven benefits for marginalised groups, and inflating private healthcare dominance.
The Argument: Balancing Public Needs Against Market Agendas
A closer look at budgetary priorities reveals a troubling shift—diverting resources from proven systems like NHM toward private-sector-oriented schemes and initiatives like medical tourism hubs. For instance, ₹7,500 crore allocated to PMJAY in 2024-25 saw only ₹6,983 crore spent, yet its 2026-27 allocation has ballooned. This comes as NHM-funded Health and Wellness Centres (HWCs) teeter on the brink of operational failure due to sustained budgetary cuts. Similarly, mental health services have received piecemeal allocations; while new institutions like NIMHANS-2 are proposed, upgrades to regional mental health institutes lack clarity in scale and funding.
The Biopharma Strategy for Healthcare Advancement—₹10,000 crore over five years—indicates a focus on creating global manufacturing hubs and clinical trials infrastructure but neglects tangible public health inputs. Expanding health and care workforce efforts, proposing 1.5 lakh allied health professionals, will face execution challenges without detailed implementation agencies or funding roadmaps.
Counter-Narrative: Innovation vs. Present Needs
Proponents argue that schemes focusing on innovation, biopharma, and medical tourism position India as a global healthcare leader while fostering economic growth. The Biopharma initiative, along with three new National Institutes of Pharmaceutical Education and Research, promises long-term systemic transformation. Additionally, medical tourism hubs could drive foreign exchange inflows while improving domestic healthcare capabilities. However, the economic benefits touted mask systemic inequities, including health access disparities. Even as these initiatives enrich private enterprise, they risk pushing India’s most vulnerable populations further into precarity.
International Comparison: Lessons from Thailand
Thailand’s Universal Healthcare Scheme provides a stark counterpoint to India’s fragmented approach. Funded directly through central taxation, Thailand guarantees virtually free, comprehensive healthcare to all its citizens. Primary healthcare infrastructure—community health centres staffed by adequately compensated professionals—forms the backbone of their system. In contrast, India’s focus on insurance-based schemes like PMJAY has led to high out-of-pocket expenses and exclusion of many marginalised groups. The contrast is instructive: where Thailand prioritises equity and accessibility, India seems to prioritise profit and commercialisation.
Assessment: Recalibrating Priorities
To address its widening healthcare inequities and systemic inefficiencies, India must decisively shift its focus from private-sector prioritisation to a robust public healthcare system. Restoring NHM allocations to 2020-21 levels, ensuring fair compensation for ASHAs and frontline workers, and operationalising HWCs are immediate necessities. Targeting universal healthcare—including preventive and mental health services—should replace the fragmented insurance and tourism-oriented healthcare models. Policymakers need to ask: whose needs are truly being served by the Union Budget?
Practice Questions for UPSC
Prelims Practice Questions
- Health expenditure as a share of GDP decreased from 0.37% to 0.28%.
- The allocation for PMJAY increased by 36% compared to 2024-25.
- The National Health Mission received increased funding compared to 2021-22.
Select the correct answer using the code given below.
- PM-JAY
- Biopharma Strategy
- National Health Mission
- International Medical Tourism
Choose the correct option from below.
Frequently Asked Questions
What are the implications of the modest increase in healthcare allocations in the Union Budget 2026-27?
The modest increase of ₹1,10,939 crore represents less than 3.5% growth in real terms, which falls short of adequately addressing India’s pressing public health challenges. With the share of health expenditure as a percentage of GDP declining to 0.28%, this trend raises concerns about the government's commitment to public health amidst rising healthcare demands.
How has the allocation for the National Health Mission (NHM) changed in the recent budget?
In the Union Budget 2026-27, the National Health Mission has experienced an 8% real-term decline in funding compared to 2021-22. This cut is alarming as NHM has consistently exceeded its budget estimates in actual expenditures, indicating a persistent unmet demand for essential health services across the country.
What are the contrasting healthcare funding priorities observed in the Union Budget 2026-27?
The Union Budget reveals a troubling shift in funding priorities, diverting resources from established systems like NHM towards private-sector initiatives. For example, the substantial increase in PMJAY's budget contrasts with budget cuts to vital public health programs, showcasing a trend toward commercialization rather than addressing fundamental public health needs.
In what ways does India's healthcare model differ from Thailand's Universal Healthcare Scheme?
India’s healthcare model relies heavily on insurance-based schemes like PMJAY, leading to high out-of-pocket costs and exclusion of marginalized populations. In contrast, Thailand's Universal Healthcare Scheme, funded by central taxation, provides comprehensive healthcare access to all citizens and prioritizes equity and accessibility in primary healthcare delivery.
What recommendations are suggested to address India's healthcare inequities and inefficiencies?
To address its healthcare inequities, it is recommended that India restore NHM funding to 2020-21 levels, ensure fair compensation for frontline workers, and operationalize Health and Wellness Centres. Additionally, a shift towards universal healthcare, particularly in preventive and mental health services, is crucial for overcoming fragmented and commercialized healthcare models.
About LearnPro Editorial Standards
LearnPro editorial content is researched and reviewed by subject matter experts with backgrounds in civil services preparation. Our articles draw from official government sources, NCERT textbooks, standard reference materials, and reputed publications including The Hindu, Indian Express, and PIB.
Content is regularly updated to reflect the latest syllabus changes, exam patterns, and current developments. For corrections or feedback, contact us at admin@learnpro.in.